Completed PHASE4 INTERVENTIONAL 2-arm NCT03657407

B&O for TLH Post-operative Pain and Nausea

Belladonna and Opium Rectal Suppository Effect on Postoperative Pain and Nausea Following Total Laparoscopic and Robotic-Assisted Hysterectomy

Sponsor: Anna Reinert

Conditions Hysterectomy Pain, Postoperative

Interventions Belladonna Opium Glycerin Suppository

Updated 11 times since 2018 Last updated: Mar 10, 2019 Started: Jun 1, 2016 Primary completion: May 31, 2017 Completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03657407, this PHASE4 trial focuses on Hysterectomy and Pain, Postoperative and remains completed. Sponsored by Anna Reinert, it has been updated 11 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Mar 2022 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 6 earlier versions

Dec 2021 — Mar 2022 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Nov 2020 — Jan 2021 [monthly]

Completed PHASE4
Sep 2019 — Nov 2020 [monthly]

Completed PHASE4
May 2019 — Sep 2019 [monthly]

Completed PHASE4
Oct 2018 — May 2019 [monthly]

Completed PHASE4

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anna Reinert
University of Maryland

Data source: Mercy Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States